PCRX

PACIRA BIOSCIENCES INC

PCRX·695127100·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-Activist

PCRX (PACIRA BIOSCIENCES INC) is held by 134 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($170.1M), VANGUARD PORTFOLIO MANAGEMENT LLC ($61M), DIMENSIONAL FUND ADVISORS LP ($53.4M). Net institutional sentiment: Mixed.

134
Holders
(9 Elite)
$917.7M
Total Value
49% (129)
Consensus
63 buying - 66 selling
13F: Insider & Congress: Updated regularly
PCRX

Smart Money Verdict

View all
Loading verdict
Held by 134 funds
9 elite

Who's Trading

Source dates: Price Oct 12, 2026 · Insiders Oct 9, 2026 · Activists Aug 7, 2026 · Congress none

InsiderRLRIKER LAURENExercise 6K shOct 8, 2026
InsiderRLRIKER LAURENSell $218KOct 8, 2026
InsiderSJSLONIN JONATHANSell $71KAug 17, 2026
Checking access…

Top Holders

Checking access…
Action
Decreased
6.7M(-0.4%)$170.1M0.0%+92.00%
0
Decreased
2.4M(-3.8%)$61M0.0%+60.84%
0
Increased
2.1M(+2.1%)$53.4M0.0%+1.24%
30
Increased
2.1M(+7.3%)$52.3M0.0%-6.46%
32
Decreased
2M(-1.6%)$49.5M0.0%+90.43%
0
Decreased
1.7M(-5.0%)$44M0.1%+0.14%
0
Decreased
1.7M(-5.2%)$42.9M0.0%+60.84%
0
Decreased
1.5M(-2.7%)$38.7M0.0%+38.84%
0
Increased
1.2M(+1.3%)$29.4M0.0%-12.27%
29
Decreased
1.1M(-17.8%)$29M0.0%+73.12%
0
Increased
1M(+21.6%)$25.8M0.0%+46.42%
34
Increased
920,217(+63.7%)$23.3M0.0%+55.97%
42
Unchanged
750,027$19M0.1%+13.21%
0
Increased
724,604(+37.5%)$18.4M0.0%+42.10%
37
Decreased
690,786(-5.6%)$17.5M0.0%+7.41%
0
Increased
563,458(+17.8%)$14.3M0.0%-14.10%
33
Increased
526,782(+1.4%)$13.4M0.0%+7.31%
28
Decreased
391,101(-0.1%)$9.9M0.0%+46.18%
0
Increased
370,092(+88.5%)$9.4M0.1%+44.29%
43
Increased
346,697(+44.2%)$8.7M0.0%+82.89%
37

Showing 1-20 of 141

1 / 8
PCRXPCRXPACIRA BIOSCIENCES INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used